Joint Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results and Reiterated FY23 System-wide Sales Guidance. Also, Roth MKM Reiterated a Buy Rating on the Stock and Raised Its Price Target From $13 to $16
在該公司公佈的第一季度財務業績好於預期並重申了23財年的全系統銷售指引後，聯合股交易走高。此外，羅斯MKM重申了對該股的買入評級，並將其目標股價從13美元上調至16美元